21 research outputs found
The epidemiology of mumps in Italy
In Italy, although vaccination has been recommended for a number of years, vaccination coverage for mumps is still sub-optimal. The objective of the present study was to evaluate the seroprevalence of mumps antibodies in the Italian population, stratified by age, gender and geographical area. The proportion of individuals positive for mumps antibodies remained stable in the age classes 0-11 months and 1 year (25.4% and 30.8%, respectively) and showed a continuous increase after the second year of life. The percentage of susceptible individuals was higher than 20% in persons 2-14 years of age and exceeded 10% in persons 15-39 years of age. No statistically significant differences were observed by gender or geographical area. Comparison between these results and the data obtained from a 1996 survey showed a statistically significant increase in seroprevalence in the age class 2-4 years. No changes were observed in the other age-groups. The results of this study confirm that the efforts made in recent years to improve vaccination coverage within the second year of life should be strengthened. \ua9 2008 Elsevier Ltd. All rights reserved
Impiego della proteina A stafilococcica per la ricerca di IgM specifiche verso il virus dell'epatite A.
La vaccinazione contro l'epatite B negli adulti a rischio. Risultati di 3 anni di follow-up
Impiego del metodo delle rette parallele per la titolazione dell'antigene di superficie del virus dell'Epatite B con tecnica immunoenzimatica
Confronto fra metodiche sierologiche per la valutazione dello stato immunitario e l'accertamento dell'infezione rubeolica in gravidanza
Results of two randomized clinical trials with the combined Diphtheria-Tetanus-Hepatitis B and Diphtheria-Tetanus-Acellular Pertussis-Hepatitis B vaccines.
--